Sort

Search

01/07/2022 Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Quilis, N, Vela, P, Caceres, BAB, Diaz-Torne, C, Calvo-Aranda, E, Sivera, F, Prada-Ojeda, A, Ruiz, FP, Pascual, E, Andres, M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7)DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27.400(Q1/1D).
01/07/2022 Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?
Sanguedolce, F, Meneghetti, I, Bevilacqua, G, Montano, B, Martinez, C, Territo, A, Balana, J, Palou, J, Breda, A. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2022; 40(7)DOI:10.1016/j.urolonc.2022.02.013. PMID:35400568. IF:2.700(Q2/5D).
01/07/2022 Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study
Puertolas-Gracia, B, Barbaglia, MG, Gotsens, M, Pares-Badell, O, Brugal, MT, Torrens, M, Trevino, L, Rodriguez-Diaz, C, Vazquez-Vazquez, JM, Pascual, A, Coromina-Gimferrer, M, Jimenez-Duenas, M, Oliva, I, Gonzalez, E, Mestre, N, Bartroli, M. Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133760. PMID:35807045. IF:3.900(Q2/4D).
01/07/2022 Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020
Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Ortiz, A, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020. NEFROLOGIA. 2022; 42(4)DOI:10.1016/j.nefro.2021.05.009. PMID:36404270. IF:2.600(Q3/6D).
01/07/2022 Impact of R-Carvedilol on beta 2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
Casabella-Ramon, S, Jimenez-Sabado, V, Tarifa, C, Casellas, S, Lu, TT, Izquierdo-Castro, P, Gich, I, Jimenez, M, Ginel, A, Guerra, JM, Chen, SRW, Benitez, R, Hove-Madsen, L. Impact of R-Carvedilol on beta 2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes. Biomedicines. 2022; 10(7)DOI:10.3390/biomedicines10071759. PMID:35885069. IF:4.700(Q1/3D).
30/06/2022 CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Canada-Garcia, JE, Moure, Z, Sola-Campoy, PJ, Delgado-Valverde, M, Cano, ME, Gijon, D, Gonzalez, M, Gracia-Ahufinger, I, Larrosa, N, Mulet, X, Pitart, C, Rivera, A, Bou, G, Calvo, J, Canton, R, Gonzalez-Lopez, JJ, Martinez-Martinez, L, Navarro, F, Oliver, A, Palacios-Baena, ZR, Pascual, A, Ruiz-Carrascoso, G, Vila, J, Aracil, B, Perez-Vazquez, M, Oteo-Iglesias, J. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Frontiers in Microbiology. 2022; 13DOI:10.3389/fmicb.2022.918362. PMID:35847090. IF:5.200(Q2/3D).
29/06/2022 Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).
28/06/2022 Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
Pollard, JA, Furutani, E, Liu, SS, Esrick, E, Cohen, LE, Bledsoe, J, Liu, CW, Lu, K, de Haro, MJR, Sumalles, J, Malsch, M, Kuniholm, A, Galvin, A, Armant, M, Kim, AS, Ballotti, K, Moreau, L, Zhou, Y, Babushok, D, Boulad, F, Carroll, C, Hartung, H, Hont, A, Nakano, T, Olson, T, Sze, SG, Thompson, AA, Wlodarski, MW, Gu, XS, Libermann, TA, D'Andrea, A, Grompe, M, Weller, E, Shimamura, A. Metformin for treatment of cytopenias in children and young adults with Fanconi anemia. Blood Advances. 2022; 6(12)DOI:10.1182/bloodadvances.2021006490. PMID:35500223. IF:7.500(Q1/2D).